Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer

Tatsuya Takayama, Taro Kubo, Ai Morikawa, Tatsuo Morita, Osamu Nagano, Hideyuki Saya

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint Dive into the research topics of 'Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences